Hyperprothrombinemia
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
| Hyperprothrombinemia Classification and external resources | |
| OMIM | 176930 |
|---|---|
| DiseasesDB | 32790 |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-632-7753
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Hyperprothrombinemia is a disorder of prothrombin which leads to hypercoagulation.
Substitution of adenine for guanine at position 20210 of the prothrombin gene, known as the prothrombin 20210a mutation, prothrombin 20210 mutation and, less precise, just factor II mutation,[1][2] leads to hypercoagulability and may be a factor that contributes to infertility. Its prevalence is thought to be approximately 2% in caucasians and 0.5% in blacks.[2]
Position 20210 falls outside of the reading frame for the protein and is thought to play a role in promoting prothrombin production; the substitution leads to high levels of prothrombin.[3]
References
- ↑ Steen CJ. Factor II. eMedicine.com. URL: http://www.emedicine.com/med/topic3494.htm. Accessed on: March 11, 2007.
- ↑ 2.0 2.1 Varga E, Moll S (2004). "Cardiology patient pages. Prothrombin 20210 mutation (factor II mutation)". Circulation 110 (3): e15–8. doi:10.1161/01.CIR.0000135582.53444.87. PMID 15262854. Free Full Text.
- ↑ Poort S, Rosendaal F, Reitsma P, Bertina R (1996). "A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis". Blood 88 (10): 3698–703. PMID 8916933.
WikiDoc Research Resources for Hyperprothrombinemia | |
|---|---|
| Articles on Hyperprothrombinemia | Most recent articles on Hyperprothrombinemia • Most cited articles on Hyperprothrombinemia • Review articles on Hyperprothrombinemia • Articles on Hyperprothrombinemia in N Eng J Med, Lancet, BMJ |
| Media (Slides, Video, Images, MP3) on Hyperprothrombinemia | Powerpoint slides on Hyperprothrombinemia • Images of Hyperprothrombinemia • Photos of Hyperprothrombinemia • Podcasts & MP3s on Hyperprothrombinemia • Videos on Hyperprothrombinemia |
| Evidence Based Medicine Regarding Hyperprothrombinemia | Cochrane Collaboration on Hyperprothrombinemia • Bandolier on Hyperprothrombinemia • TRIP on Hyperprothrombinemia |
| Cost Effectiveness of Hyperprothrombinemia | Cost Effectiveness of Hyperprothrombinemia |
| Clinical Trials Involving Hyperprothrombinemia | Ongoing Trials on Hyperprothrombinemia at Clinical Trials.gov • Trial results on Hyperprothrombinemia • Clinical Trials on Hyperprothrombinemia at Google |
| Guidelines / Policies / Government Resources (FDA/CDC) Regarding Hyperprothrombinemia | US National Guidelines Clearinghouse on Hyperprothrombinemia • NICE Guidance on Hyperprothrombinemia • NHS PRODIGY Guidance • FDA on Hyperprothrombinemia • CDC on Hyperprothrombinemia |
| Textbook Information on Hyperprothrombinemia | Books and Textbook Information on Hyperprothrombinemia |
| Pharmacology Resources on Hyperprothrombinemia | Dosing of Hyperprothrombinemia • Drug interactions with Hyperprothrombinemia • Side effects of Hyperprothrombinemia • Allergic reactions to Hyperprothrombinemia • Overdose information on Hyperprothrombinemia • Carcinogenicity information on Hyperprothrombinemia • Hyperprothrombinemia in pregnancy • Pharmacokinetics of Hyperprothrombinemia • |
| Genetics, Pharmacogenomics, and Proteinomics of Hyperprothrombinemia | Genetics of Hyperprothrombinemia • Pharmacogenomics of Hyperprothrombinemia • Proteomics of Hyperprothrombinemia |
| Newstories on Hyperprothrombinemia | Hyperprothrombinemia in the news • Be alerted to news on Hyperprothrombinemia • News trends on Hyperprothrombinemia |
| Commentary on Hyperprothrombinemia | Blogs on Hyperprothrombinemia |
| Patient Resources on Hyperprothrombinemia | Patient resources on Hyperprothrombinemia • Discussion groups on Hyperprothrombinemia • Patient Handouts on Hyperprothrombinemia • Directions to Hospitals Treating Hyperprothrombinemia • Risk calculators and risk factors for Hyperprothrombinemia |
| Healthcare Provider Resources on Hyperprothrombinemia | Symptoms of Hyperprothrombinemia • Causes & Risk Factors for Hyperprothrombinemia • Diagnostic studies for Hyperprothrombinemia • Treatment of Hyperprothrombinemia |
| Continuing Medical Education (CME) Programs on Hyperprothrombinemia | CME Programs on Hyperprothrombinemia |
| International Resources on Hyperprothrombinemia | Hyperprothrombinemia en Espanol • Hyperprothrombinemia en Francais |
| Business Resources on Hyperprothrombinemia | Hyperprothrombinemia in the Marketplace • Patents on Hyperprothrombinemia |
| Informatics Resources on Hyperprothrombinemia | List of terms related to Hyperprothrombinemia |
| ||||
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
